Telavancin ( DrugBank: Telavancin )


1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis1

299. Cystic fibrosis


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03172793
(ClinicalTrials.gov)
August 8, 20179/5/2017Telavancin Pharmacokinetics in Cystic Fibrosis PatientsPharmacokinetics and Tolerability of Telavancin at Differing Dosing Regimens in Cystic Fibrosis Adults Admitted With Acute Pulmonary ExacerbationsCystic FibrosisDrug: Telavancin InjectionJoseph L. Kuti, PharmDCumberland Pharmaceuticals, Inc.Completed18 YearsN/AAll18Phase 4United States